Citigroup »

Caris Life Sciences shares owned by Citigroup

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.4M 77k 17.88

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
J. H. Whitney Equity Partners VI
FMR
Coatue Management
T. Rowe Price Investment Management
Braidwell
PointState Capital
BlackRock
Neuberger Berman Group
Vanguard Portfolio Management
Vanguard Capital Management
OrbiMed Advisors
UBS Group
Thomas Stevens, CFA"
Duquesne Family Office

View all funds holding Caris Life Sciences